NMRA Consolidated Dossier Medical Device Registration: Sri Lanka 2025 Step-by-Step Guide

Quick answer

From 5 August 2025, Sri Lanka's National Medicines Regulatory Authority (NMRA) requires new medical device applications to be submitted as a consolidated dossier rather than through the older sequential filing route. The Medical Device Registration Division (MDRD) evaluates one complete technical package against the published Guideline for consolidated dossier application submission and evaluation and the Checklist for document accepting of consolidated medical device application. Applicants first complete NMRA's Google Form for dossier acceptance, then deliver the physical dossier with two copies of the relevant checklist at the accepting point—Annex 1 for new consolidated applications and Annex 2 for re-registration. Foreign manufacturers must appoint a Marketing Authorization Holder (MAH) in Sri Lanka. All documents should be in English, on A4 paper, with a numbered index, and include core items such as Schedule I Form A, a free sale certificate, and ISO 13485 evidence as listed on nmra.gov.lk.

Who this applies to

This guide is for regulatory affairs teams, local distributors, and legal representatives preparing NMRA consolidated dossier medical device registration for Sri Lanka in 2025 and beyond.

Roles and scenarios:

Product scope: The consolidated dossier applies to new medical device applications submitted on or after the 5 August 2025 effective date. It covers the full range of medical devices NMRA registers under its medical device programme—diagnostic equipment, surgical instruments, implants, IVDs, and related consumables where NMRA oversight applies. If you are unsure whether your product falls under NMRA medical device registration rather than drug-only oversight, confirm classification against current NMRA medical device guidance on nmra.gov.lk before building the dossier.

Who is outside immediate scope: Legacy applications accepted under the pre-August 2025 sequential process may follow different administrative rules until NMRA publishes a specific transition notice. This article focuses on the consolidated dossier route for new applications from the effective date forward.

Consolidated dossier vs legacy sequential filing

Understanding the shift from sequential filing to a single consolidated package is central to Sri Lanka medical device registration planning in 2025.

Under the legacy sequential filing approach, applicants often submitted documentation in stages—initial administrative forms followed by supplementary technical files as MDRD requested them. That model created multiple acceptance touchpoints, longer back-and-forth cycles, and inconsistent completeness at first review.

The consolidated dossier model requires applicants to compile all required documents into one indexed submission before the acceptance appointment. MDRD evaluates completeness against the published checklist at intake; incomplete dossiers should be corrected before acceptance rather than patched across later rounds.

If your team previously registered devices in Sri Lanka using the older workflow, treat the consolidated dossier as a full rebuild, not a document append. Map every legacy file to the new checklist annexes before scheduling acceptance.

Step-by-step workflow

Follow this sequence when preparing NMRA consolidated dossier medical device registration for a new device.

Step 1: Confirm eligibility and appoint an MAH

Verify that your product requires NMRA medical device registration and that you are submitting a new application covered by the 5 August 2025 consolidated framework. Foreign manufacturers must confirm that a Marketing Authorization Holder (MAH) is formally designated in Sri Lanka before dossier work begins. The MAH is the local entity NMRA expects to coordinate submission, respond to queries, and maintain registration obligations.

Step 2: Download official guidance and the correct checklist annex

From nmra.gov.lk, obtain:

• The Guideline for consolidated dossier application submission and evaluation
• The Checklist for document accepting of consolidated medical device application
• Supporting requirement pages covering Schedule I Form A, free sale certificate, ISO 13485, and related technical documents

Select Annex 1 for new consolidated applications or Annex 2 for re-registration. Do not mix annexes—MDRD uses the annex to classify your submission type at acceptance.

Step 3: Build the technical dossier with a numbered index

Assemble all checklist items into one logical dossier:

1. Create a numbered index listing every document, annex reference, and page range.
2. Prepare each document in English on A4 paper.
3. Include Schedule I Form A as prescribed on NMRA pages.
4. Attach a valid free sale certificate from the country of origin or recognized reference market as NMRA requires.
5. Include ISO 13485 certification (or equivalent quality-system evidence cited on nmra.gov.lk).
6. Add clinical, labeling, manufacturing, and post-market documentation per the checklist—not only the three items above.

Bind or folder the dossier so MDRD reviewers can cross-reference index numbers without disassembly.

Step 4: Complete the Google Form for dossier acceptance

Before visiting the accepting point, complete NMRA's official Google Form for dossier acceptance:

https://docs.google.com/forms/d/e/1FAIpQLSf8-B5VcCc1VXW7WL0fUhRiiap2BH6fQ6DvN2a2Yj1JpzLXig/viewform

The form initiates the administrative acceptance workflow. Enter accurate product, MAH, and contact details—they must match the physical dossier and checklist exactly. Keep a screenshot or confirmation email for your regulatory records.

Step 5: Print two copies of the relevant checklist

Print two copies of the completed checklist:

• Annex 1 — consolidated new application
• Annex 2 — re-registration

Tick every line item you are submitting. Unsigned or partially completed checklists are a common reason for acceptance delays.

Step 6: Submit at the accepting point

Deliver to the NMRA accepting point:

• The full consolidated dossier (original set plus copies as NMRA specifies in the guideline)
• Two copies of the relevant checklist (Annex 1 or Annex 2)

MDRD staff verify dossier completeness against the checklist at intake. If items are missing, expect the submission to be held or returned for correction before formal acceptance.

Step 7: Coordinate with MDRD during evaluation

After acceptance, MDRD evaluates the dossier under the consolidated guideline. For status questions or clarifications, contact MDRD through the published mailboxes:

• pa6@nmra.gov.lk
• aa16@nmra.gov.lk
• aa20@nmra.gov.lk

Use a single thread per application, reference your product trade name and checklist submission date, and attach only supplementary items MDRD explicitly requests.

Step 8: Respond to deficiencies and obtain registration

If MDRD issues a deficiency letter, respond with indexed supplementary pages—do not revert to sequential partial submissions. Once evaluation is complete, NMRA issues the marketing authorization outcome applicable to your device class and registration type.

Comparison table: submission routes at a glance

Key documents checklist

Use this practitioner checklist alongside NMRA's official Checklist for document accepting of consolidated medical device application. Every item below must appear in your numbered index.

Administrative and legal

• Schedule I Form A completed per nmra.gov.lk specifications
• MAH appointment evidence for foreign manufacturers (authorization letter, company profile)
• Manufacturing authorization or license from country of origin
• Free sale certificate from competent authority or recognized reference country
• Power of attorney or local representative letter where NMRA templates require it

Quality management

• ISO 13485 certificate (scope must cover the manufacturing site and product category)
• Most recent surveillance audit report if requested in NMRA pages
• Quality manual summary or QMS overview tied to the certified site

Technical and clinical

• Device description, intended use, and classification rationale
• Labels and IFU in English (Sri Lanka market version)
• Risk management file summary (ISO 14971 alignment)
• Clinical evaluation or literature summary appropriate to device class
• Sterilization validation for sterile devices
• Biocompatibility summaries for patient-contacting materials

Submission mechanics

• Numbered index covering all volumes
• All pages on A4, English
• Two copies of Annex 1 (new) or Annex 2 (re-registration) attached at acceptance
• Google Form for dossier acceptance submitted before physical delivery

Cross-check each box against the official checklist PDF—NMRA may update line items without changing the consolidated framework.

Common pitfalls

Submitting before completing the Google Form. Physical dossiers delivered without a prior form submission may not enter the acceptance queue. Always complete the form first and retain confirmation.

Using Annex 2 for a new device. Annex 1 and Annex 2 are not interchangeable. New consolidated applications require Annex 1; re-registration requires Annex 2.

Providing only one checklist copy. NMRA requires two copies of the relevant checklist at the accepting point. Single-copy submissions create administrative rejection risk before technical review begins.

Missing MAH documentation for foreign manufacturers. Sri Lanka expects a local Marketing Authorization Holder. Dossiers filed directly by overseas offices without MAH evidence typically fail acceptance.

Non-English or non-A4 documents. The consolidated framework specifies English and A4. Mixed-language inserts or irregular paper sizes slow intake review.

Index gaps. A numbered index that omits annexes, revisions, or supplemental letters forces MDRD to treat the dossier as incomplete even when individual documents are strong.

ISO 13485 scope mismatch. Certificates must cover the manufacturing site and product category for the device under registration. Generic corporate ISO certificates without medical device scope are frequently queried.

Free sale certificate expiry or wrong issuing body. Confirm the certificate issuer is recognized under NMRA's published expectations and that validity covers the acceptance date.

Reverting to sequential partial sends after acceptance. Once on the consolidated path, send deficiency responses as indexed addenda—not piecemeal email attachments across unrelated threads.

Ignoring published MDRD mailboxes. Route formal correspondence to pa6@nmra.gov.lk, aa16@nmra.gov.lk, and aa20@nmra.gov.lk rather than informal contacts that may not be logged in the registration file.

FAQ

What is NMRA consolidated dossier medical device registration?

It is NMRA's requirement—effective 5 August 2025 for new applications—to submit all medical device registration documents in a single consolidated dossier evaluated against the published Guideline for consolidated dossier application submission and evaluation and the official acceptance checklist, rather than filing documents sequentially over multiple rounds.

How do I register a medical device in Sri Lanka under the 2025 rules?

Confirm product classification, appoint an MAH if you are a foreign manufacturer, download the guideline and checklist from nmra.gov.lk, build an English A4 dossier with a numbered index, complete the Google Form for dossier acceptance, print two copies of Annex 1 (new) or Annex 2 (re-registration), and submit at the NMRA accepting point. Track evaluation through MDRD mailboxes pa6@nmra.gov.lk, aa16@nmra.gov.lk, and aa20@nmra.gov.lk.

Is a Marketing Authorization Holder (MAH) necessary in Sri Lanka?

Yes, for foreign manufacturers. NMRA expects a local Marketing Authorization Holder to coordinate the consolidated dossier, represent the manufacturer in Sri Lanka, and maintain registration responsibilities. Importers and distributors should confirm MAH status before dossier assembly—not after submission.

What is the difference between Annex 1 and Annex 2?

Annex 1 supports new consolidated medical device applications. Annex 2 supports re-registration under the consolidated framework. Submit two copies of the annex that matches your application type with the physical dossier at the accepting point.

Where do I submit the dossier acceptance form?

Use NMRA's official Google Form: https://docs.google.com/forms/d/e/1FAIpQLSf8-B5VcCc1VXW7WL0fUhRiiap2BH6fQ6DvN2a2Yj1JpzLXig/viewform. Complete it before delivering the physical dossier. Details entered in the form must match the MAH, product name, and checklist.

What documents must be in the consolidated dossier?

At minimum, NMRA pages cite Schedule I Form A, a free sale certificate, ISO 13485 evidence, and the full set of items on the Checklist for document accepting of consolidated medical device application. All documents must be in English, on A4 paper, and listed in a numbered index. Consult the current checklist on nmra.gov.lk for the authoritative list.

Does the consolidated dossier apply to renewals?

Re-registration uses the consolidated framework with Annex 2 instead of Annex 1. The same principles apply—complete dossier, Google Form, two checklist copies, English A4 indexed submission—even when the device already holds a prior NMRA registration.

Who do I contact at NMRA MDRD for application status?

Email pa6@nmra.gov.lk, aa16@nmra.gov.lk, or aa20@nmra.gov.lk with your product name, MAH details, and acceptance date. Keep one consolidated email thread per application to align with MDRD's evaluation record.

Official sources

• National Medicines Regulatory Authority (NMRA) — consolidated dossier announcement and medical device registration pages: https://nmra.gov.lk
• Guideline for consolidated dossier application submission and evaluation — published on nmra.gov.lk (Medical Device Registration Division)
• Checklist for document accepting of consolidated medical device application — published on nmra.gov.lk (Annex 1 new applications; Annex 2 re-registration)
• Google Form for dossier acceptance — https://docs.google.com/forms/d/e/1FAIpQLSf8-B5VcCc1VXW7WL0fUhRiiap2BH6fQ6DvN2a2Yj1JpzLXig/viewform
• Schedule I Form A, free sale certificate, ISO 13485, and related document requirements — NMRA medical device registration resource pages at https://nmra.gov.lk
• MDRD contact mailboxes: pa6@nmra.gov.lk | aa16@nmra.gov.lk | aa20@nmra.gov.lk